IPD — ImpediMed Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$178.05m
- AU$142.42m
- AU$11.34m
- 56
- 21
- 47
- 39
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -15.5 | -17.3 | -13.8 | -18.8 | -19.7 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -19.6 | -19.2 | -13.3 | -15.7 | -18 |
Capital Expenditures | -2.22 | -2.16 | -2.46 | -5.22 | -6.04 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.459 | 0 | — | — | — |
Sale of Business | |||||
Cash from Investing Activities | -1.76 | -2.16 | -2.46 | -5.22 | -6.04 |
Financing Cash Flow Items | -0.018 | -2.68 | -0.133 | -2.21 | -1.67 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.145 | 30.2 | 16.5 | 39.9 | 27.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -20 | 8.33 | 0.018 | 21 | 4.98 |